Patient demographics
|
Male gender
|
45 (63.4)
|
80 (56.3)
|
.38
|
1.34 (0.75–2.41)
|
Age > 65
|
32 (43.7)
|
73 (51.4)
|
.31
|
0.77 (0.44–1.38)
|
Medical history
|
Diabetes mellitus
|
19 (26.8)
|
50 (35.2)
|
.28
|
0.67 (0.36–1.26)
|
Corticosteroid therapy (prior 6 months)
|
32 (45.1)
|
47 (33.1)
|
.10
|
1.66 (0.93–2.97)
|
Neutropenia
|
14 (19.7)
|
9 (6.3)
|
.005
|
3.62 (1.49–8.87)
|
Solid organ transplantation
|
14 (19.7)
|
23 (16.2)
|
.57
|
1.27 (0.61–2.65)
|
Hematologic malignancy
|
18 (25.4)
|
9 (6.3)
|
<.001
|
5.01 (2.12–11.87)
|
Non-hematologic malignancy
|
12 (16.9)
|
33 (23.2)
|
.37
|
0.67 (0.32–1.40)
|
Chronic urologic disorder
|
13 (18.3)
|
33 (23.2)
|
.48
|
0.74 (0.36–1.52)
|
Chronic pulmonary disease
|
7 (9.9)
|
19 (13.4)
|
.51
|
0.71 (0.28–1.77)
|
Recurrent urinary tract infections
|
7 (9.9)
|
14 (9.9)
|
1.00
|
1.00 (0.38–2.60)
|
Clinical presentation
|
Fever (temperature > 38.5 °C)
|
49 (69.0)
|
104 (73.2)
|
.31
|
0.81 (0.43–1.53)
|
EMV-score < 15
|
21 (30.6)
|
29 (20.4)
|
.23
|
1.57 (0.81–3.02)
|
Hypotensiona
|
18 (25.4)
|
23 (16.2)
|
.14
|
1.79 (0.89–3.63)
|
Current antibiotic useb
|
49 (69.0)
|
37 (26.1)
|
<.001
|
6.32 (3.38–11.84)
|
Antibiotic usage preceding 2 months
|
67 (94.4)
|
67 (47.2)
|
<.001
|
18.75 (6.49–54.19)
|
ICU/MCU > 2 days
|
11 (15.5)
|
7 (4.9)
|
.02
|
3.54 (1.31–9.57)
|
ICU/MC preceding 6 months
|
23 (32.4)
|
16 (11.3)
|
<.001
|
3.77 (1.84–7.75)
|
Hospital stay preceding 6 months
|
49 (69.0)
|
65 (45.8)
|
.001
|
2.64 (1.45–4.82)
|
Hospitalization > 5 days
|
32 (45.1)
|
28 (19.7)
|
<.001
|
3.34 (1.79–6.24)
|
Prior-DRPc
|
42 (59.2)
|
27 (19.0)
|
<.001
|
6.17 (3.28–11.61)
|
Source of infection
| | |
.06
|
–
|
Urinary tract
|
23 (32.4)
|
68 (47.9)
| | |
Intra-abdominal tract
|
22 (31.0)
|
44 (31.0)
| | |
Respiratory tract
|
3 (4.3)
|
9 (6.4)
| | |
Skin/soft tissue
|
6 (8.6)
|
4 (2.8)
| | |
Other
|
7 (9.9)
|
7 (4.9)
| | |
Unidentified
|
10 (14.1)
|
10 (7.0)
| | |